Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors
Chris A. Brosey, Jerry H. Houl, Panagiotis Katsonis, et al.
Progress in Biophysics and Molecular Biology (2021) Vol. 163, pp. 171-186
Open Access | Times Cited: 53

Showing 26-50 of 53 citing articles:

Crystal structure and biochemical activity of the macrodomain from rubella virus p150
Guido A. Stoll, Nikos Nikolopoulos, Haoming Zhai, et al.
Journal of Virology (2024) Vol. 98, Iss. 2
Open Access | Times Cited: 1
GS-441524-Diphosphate-Ribose Derivatives as Nanomolar Binders and Fluorescence Polarization Tracers for SARS-CoV-2 and Other Viral Macrodomains
Kewen Peng, Shamar D. Wallace, Saket R. Bagde, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 5, pp. 1093-1105
Open Access | Times Cited: 1
MDA5 Is a Major Determinant of Developing Symptoms in Critically Ill COVID-19 Patients
Amit K. Maiti
Clinical Reviews in Allergy & Immunology (2024)
Closed Access | Times Cited: 1
Synthesis of bis-furyl-pyrrolo[3,4-b]pyridin-5-ones via Ugi–Zhu reaction and in vitro activity assays against human SARS-CoV-2 and in silico studies on its main proteins
Ivette Morales-Salazar, Flora P. Montes-Enríquez, Carlos E. Garduño-Albino, et al.
RSC Medicinal Chemistry (2022) Vol. 14, Iss. 1, pp. 154-165
Open Access | Times Cited: 8
Improved understanding of biorisk for research involving microbial modification using annotated sequences of concern
Gene D. Godbold, F. Curtis Hewitt, Anthony D. Kappell, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 4
Comprehensive Understanding of the Kinetic Behaviors of Main Protease from SARS-CoV-2 and SARS-CoV: New Data and Comparison to Published Parameters
Fangya Li, Tingting Fang, Guo Feng, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4605-4605
Open Access | Times Cited: 4
Anti‐SARS‐CoV‐2 Inhibitory Profile of New Quinoline Compounds in Cell Culture‐Based Infection Models
Lars Herrmann, Friedrich Hahn, Christina Wangen, et al.
Chemistry - A European Journal (2021) Vol. 28, Iss. 4
Open Access | Times Cited: 11
Decoding Cancer Variants of Unknown Significance for Helicase–Nuclease–RPA Complexes Orchestrating DNA Repair During Transcription and Replication
Susan E. Tsutakawa, Albino Bacolla, Panagiotis Katsonis, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 10
The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signalling
Lillian Cristina Russo, Rebeka Tomasin, Isaac de Araújo Matos, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 9
An efficient chemical screening method for structure-based inhibitors to nucleic acid enzymes targeting the DNA repair-replication interface and SARS CoV-2
Davide Moiani, Todd Link, Chris A. Brosey, et al.
Methods in enzymology on CD-ROM/Methods in enzymology (2021), pp. 407-431
Open Access | Times Cited: 7
Investigation of the binding and dynamic features of A.30 variant revealed higher binding of RBD for hACE2 and escapes the neutralizing antibody: A molecular simulation approach
Athar Shafiq, Farrukh Zubair, Amna Ambreen, et al.
Computers in Biology and Medicine (2022) Vol. 146, pp. 105574-105574
Open Access | Times Cited: 5
Targeting SARS-CoV-2 Macrodomain-1 to Restore the Innate Immune Response Using In Silico Screening of Medicinal Compounds and Free Energy Calculation Approaches
Anwar Mohammad, Eman Alshawaf, Hossein Arefanian, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1907-1907
Open Access | Times Cited: 2
A molecular toolbox for ADP-ribosyl binding proteins
Sven T. Sowa, Albert Galera‐Prat, Sarah Wazir, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
PARP1 as an Epigenetic Modulator: Implications for the Regulation of Host-Viral Dynamics
Asher A. Sobotka, Italo Tempera
Pathogens (2024) Vol. 13, Iss. 2, pp. 131-131
Open Access
Synthesis of Structural ADP-Ribose Analogues as Inhibitors for SARS-CoV-2 Macrodomain 1
Koen J. Rijpkema, M. Schuller, Miriam S. van der Veer, et al.
Organic Letters (2024) Vol. 26, Iss. 27, pp. 5700-5704
Open Access
Design, synthesis, and structure–activity relationships of xanthine derivatives as broad-spectrum inhibitors of coronavirus replication
Xiaofang Chen, Xiaotian Ding, Cong Bian, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107925-107925
Closed Access
Identification of a series of pyrrolo-pyrimidine based SARS-CoV-2 Mac1 inhibitors that repress coronavirus replication
Jessica J. Pfannenstiel, Men Thi Hoai Duong, Daniel Cluff, et al.
(2024)
Open Access
A goldilocks computational protocol for inhibitor discovery targeting DNA damage responses including replication-repair functions
Davide Moiani, John A. Tainer
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Computational Investigations of Traditional Chinese Medicinal Compounds against the Omicron Variant of SARS-CoV-2 to Rescue the Host Immune System
Ziad Tareq Naman, Salim Kadhim, Zahraa J. K. Al-Isawi, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 6, pp. 741-741
Open Access | Times Cited: 3
CoVEx: SARS-CoV-2 Mutation Explorer for genomic surveillance
Melany Calderón-Osorno, Estela Cordero-Laurent, Francisco Duarte-Martínez
Infection Genetics and Evolution (2023) Vol. 116, pp. 105521-105521
Open Access | Times Cited: 1
Antiparasitic Drugs against SARS-CoV-2: A Comprehensive Literature Survey
Estefanía Calvo‐Álvarez, Maria Dolci, Federica Perego, et al.
Microorganisms (2022) Vol. 10, Iss. 7, pp. 1284-1284
Open Access | Times Cited: 2
The renaissance in biophysics and molecular biology enabled by the interface of DNA repair and replication with cancer
Xiaodong Zhang, Tom L. Blundell, John A. Tainer
Progress in Biophysics and Molecular Biology (2021) Vol. 163, pp. 1-4
Open Access | Times Cited: 1
Free Energy Landscapes and Residue Network Analysis for Six SARS-CoV-2 Targets in Complex with Plausible Phytochemical Inhibitors from Withania Somnifera: 1 µS Molecular Dynamics Simulations
Pratap Parida, Dipak Paul, Debamitra Chakravorty
(2021)
Open Access | Times Cited: 1
Virtual article collection on infectious diseases
Delphine Dean
Progress in Biophysics and Molecular Biology (2022) Vol. 171, pp. 2-3
Open Access
1H, 13C, 15N backbone resonance assignment of apo and ADP-ribose bound forms of the macro domain of Hepatitis E virus through solution NMR spectroscopy
Maria D. Politi, Angelo Gallo, Georgios Bouras, et al.
Biomolecular NMR Assignments (2022) Vol. 17, Iss. 1, pp. 1-8
Open Access

Scroll to top